Enzo Biochem Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Enzo Biochem Inc inventory turnover ratio, the Enzo Biochem Inc's ability to sell and replace its inventory in the third quarter 2025, sequentially increased to 1.88 in the third quarter 2025, yet the ratio remained below the average, as ENZ's market remain challenging.Average inventory processing period, for the Enzo Biochem Inc in Apr 30 2025 quarter, has decreased to 194 days, compare to 197 days, in the Jan 31 2025 quarter.

Within Healthcare sector 236 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1350 in the second quarter 2025, to 1442.

ENZ Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Enzo Biochem Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ENZ Inventory Turnover Ratio	(Apr 30 2025) III. Quarter	(Jan 31 2025) II. Quarter	(Oct 31 2024) I. Quarter	(Jul 31 2024) IV. Quarter	(Apr 30 2024) III. Quarter
Y / Y Inventory Growth	-21.98 %	-23.24 %	-15.85 %	-13.94 %	-52.1 %
Y / Y Cost of Sales Growth	-12.45 %	-	-15.4 %	2.89 %	-70.36 %
Inventory Turnover Ratio (TTM)	1.88	-	2.34	2.34	2.24
ENZ's Total Ranking	# 1442	# 1350	# 661	#	#
Average inventory processing period	194	-	156	156	163
Seq. Inventory Growth	-4.56 %	-6.32 %	-6.45 %	-6.72 %	-6.1 %
Seq. Cost of Sales Growth	-	-	-14.51 %	0.4 %	-0.92 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 16
Healthcare Sector	# 237
Overall Market	# 1442

Inventory Turnover Ratio Statistics
High	Average	Low
7.63	5.18	1.85
(Oct 31 2019)		(Jan 31 2025)

ENZ Company Profile >> Back to ENZ Efficiency Comparisons >> Compare ENZ Inventory Turnover Ratio to its Competitors

Financial Statements
Enzo Biochem Inc's Inventories	$ 6 Millions	Visit ENZ's Balance sheet
Enzo Biochem Inc's Cost of Revenues TTM	$ 12 Millions	Visit ENZ's Income Statement
What are ENZ's Sales?		Visit ENZ's Sales by Segment

Other Inventory Turnover Ratios
Enzo Biochem Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ENZ's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ENZ's Competitors
Inventory Turnover Ratio for ENZ's Suppliers
Inventory Turnover Ratio for ENZ's Customers

You may also want to know
ENZ's Sales Growth Rates	ENZ's Pe Price to earnings ratio	ENZ's Receivables Turnover Ratio	ENZ's Stock Quote
ENZ's Net Income Growth Rates	ENZ's Ps Price to Sales ratio	ENZ's Sales per Employee	ENZ's Asset Turnover Ratio
ENZ's Net Margin	ENZ's Pb Price to Book ratio	ENZ's Financial Strength Ratios	ENZ's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Apr 30 2025, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Apr 30 2025	Inventories at quarter ending Apr 30 2025
Zai Lab Limited	5.55	$ 143.479 Millions	$ 26 Millions
Moderna Inc	5.52	$ 1,458.000 Millions	$ 264 Millions
Veracyte Inc	5.42	$ 116.021 Millions	$ 21 Millions
Strata Skin Sciences Inc	5.42	$ 14.000 Millions	$ 3 Millions
Exact Sciences Corporation	5.39	$ 812.749 Millions	$ 151 Millions
23andme Holding Co	5.35	$ 89.000 Millions	$ 17 Millions
Harrow Inc	5.29	$ 54.216 Millions	$ 10 Millions
Scilex Holding Company	5.21	$ 14.233 Millions	$ 3 Millions
Inotiv Inc	5.15	$ 162.822 Millions	$ 32 Millions
Cryoport inc	5.09	$ 118.336 Millions	$ 23 Millions
Henry Schein Inc	4.91	$ 8,665.000 Millions	$ 1,766 Millions
Integer Holdings Corporation	4.86	$ 1,270.000 Millions	$ 261 Millions
Bristol myers Squibb Company	4.84	$ 14,069.000 Millions	$ 2,908 Millions
West Pharmaceutical Services Inc	4.78	$ 1,895.000 Millions	$ 397 Millions
Align Technology inc	4.73	$ 1,199.000 Millions	$ 254 Millions
Adm Tronics Unlimited Inc	4.68	$ 1.801 Millions	$ 0 Millions
Steris Plc	4.63	$ 3,056.751 Millions	$ 661 Millions
Ufp Technologies Inc	4.51	$ 388.000 Millions	$ 86 Millions
Envista Holdings Corporation	4.46	$ 1,150.000 Millions	$ 258 Millions
Incyte Corporation	4.41	$ 324.300 Millions	$ 73 Millions
Integrated Biopharma Inc	4.40	$ 48.000 Millions	$ 11 Millions
Lifeward ltd	4.29	$ 16.471 Millions	$ 4 Millions
Alnylam Pharmaceuticals Inc	4.24	$ 322.083 Millions	$ 76 Millions
Logicmark Inc	4.19	$ 3.389 Millions	$ 1 Millions
Transmedics Group Inc	4.15	$ 197.880 Millions	$ 48 Millions
Escalon Medical Corp	4.12	$ 7.089 Millions	$ 2 Millions
Teva Pharmaceutical Industries Limited	4.09	$ 8,447.000 Millions	$ 2,065 Millions
Organogenesis Holdings Inc	4.08	$ 111.641 Millions	$ 27 Millions
Koru Medical Systems Inc	4.07	$ 12.809 Millions	$ 3 Millions
Medinotec Inc	4.06	$ 4.142 Millions	$ 1 Millions

Date modified: 2026-07-07T10:39:21+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.